The EEA1 Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population with targeted disruption of the EEA1 gene in the HAP1 cell line. This loss-of-function model is specifically designed for investigating early endosome dynamics, endosomal maturation, and EEA1-dependent trafficking processes. The polyclonal nature offers a heterogeneous mixture of knockout cells, enabling reproducible and scalable assessments of EEA1 deficiency in pooled formats suitable for a range of molecular and cellular studies.
HAP1 is a near-haploid human cell line originating from the KBM-7 chronic myeloid leukemia (CML) line. Its haploid karyotype simplifies genetic analyses and knockout generation, while its hematopoietic cancer background provides a clinically relevant model for cancer biology. HAP1 cells exhibit rapid growth and are a well-established platform for CRISPR-based functional genomics, particularly in studying signaling, drug resistance, and autophagy.
EEA1 acts as a tethering factor on early endosomes, recognizing phosphatidylinositol 3-phosphate (PtdIns3P) through its FYVE domain and binding active Rab5-GTP. This dual interaction promotes endosome docking and fusion, driving endosomal maturation. EEA1 functions downstream of the PIK3C3 (Vps34) complex and Rab5 GTPase, and partners with rabenosyn-5, the Vps34/p150 complex, and Beclin1. It engages SNARE proteins syntaxin 13, syntaxin 6, and VAMP4 to execute membrane fusion. Consequently, EEA1 governs endocytosis, phagocytosis, vesicle-mediated transport, and autophagy.
In the HAP1 chronic myeloid leukemia model, EEA1 knockout provides a valuable tool to investigate how early endosomal trafficking influences oncogenic signaling and drug responses. Disruption of EEA1 can alter endocytic uptake of growth factors, receptor recycling, and autophagy, processes frequently dysregulated in cancer. The near-haploid genome of HAP1 minimizes genetic redundancy, maximizing the phenotypic impact of EEA1 loss. This system is also relevant for neurodegenerative and infectious disease research, where endosomal dysfunction is a known contributor.
The EEA1 Knockout HAP1 Polyclonal Cells are well-suited for a variety of experimental approaches. Researchers can perform endocytosis uptake assays with fluorescent cargo, live-cell imaging of endosome dynamics, and immunofluorescence microscopy to visualize endosomal structures. Biochemical analyses such as co-immunoprecipitation and western blotting enable characterization of EEA1 interaction partners, while RT-qPCR allows profiling of trafficking-related gene expression. The model is particularly valuable for autophagy studies, cancer cell biology, and drug delivery mechanism investigations. For further information or to request a quote, please contact Ascent Research.
